External radiation exposure, excretion, and effective half-life in 177Lu-PSMA-targeted therapies

by J. Kurth, B. J. Krause, S. M. Schwarzenböck, L. Stegger, M. Schäfers, K. Rahbar
Published 2018-04-01

Worth a local treatment? – Analysis of modern radiotherapy concepts for oligometastatic prostate cancer

by M. Oertel, S. Scobioala, K. Kroeger, A. Baehr, L. Stegger, U. Haverkamp, M. Schäfers, H.-T. Eich
Published 2018-09-01